Notify me when DePinho Ronald A files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| CARA | TVARDI THERAPEUTICS, INC. | Common Stock, par value $0.001 per share | 6.7% | $25.7M | -$6.35M | 626K | -19.8% | Ronald A. DePinho | 30 Sep 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|